Stroke treatment and prevention: Five new things

Neurology

Volumn 75, Issue 18 SUPPL.1, 2010, Pages

  Wu, Tzu Ching ^a   Grotta, James C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DABIGATRAN; DESMOTEPLASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CAROTID ARTERY STENTING; CLINICAL TRIAL; DRUG COST; DRUG DOSE ESCALATION; DRUG MEGADOSE; ENDARTERECTOMY; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; PATIENT CARE; PRIORITY JOURNAL; STROKE;

ANTICOAGULANTS; CLINICAL TRIALS AS TOPIC; ENDARTERECTOMY, CAROTID; HUMANS; STROKE; THROMBOLYTIC THERAPY;

EID: 78650140000     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fb3616     Document Type: Article

References (14)

1. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.
2. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterec-tomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.
3. Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med;363:11-23.
4. Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stent-ing Study): an interim analysis of a randomised controlled trial. Lancet;375:985-997.
5. Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol;9:353-362.
6. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
7. Albers GW, Olivot JM. Intravenous alteplase for ischaemic stroke. Lancet 2007;369:249-250.
8. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004;61:346-350.
9. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
10. Parsons MW. Perfusion CT: is it clinically useful? Int J Stroke 2008;3:41-50.
11. Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. Stroke 2008;39:1621-1628.
12. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmote-plase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141-150.
13. Haley EC Jr, Thompson JL, Grotta JC, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke 2010;41:707-711.
14. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20-28.